Cardano ADA/USD has spiked over 100% in the last 3 -days and is currently seeing high interest by investors on social media platforms.
What Happened: Cardano was among the most mentioned cryptocurrencies on Twitter at press time, as per data from Cointrendz.com.
See Also: How To Buy Cardano (ADA)
In the early hours of Tuesday, ADA traded 1% lower at $2.79 over 24 hours and fell 2.77% over seven days.
ADA traded 0.42% and 4.16% lower against Bitcoin BTC/USD and Ethereum ETH/USD respectively over 24 hours.
Since the year began, ADA has soared 1,492.46%. The cryptocurrency hit an all-time high of $2.97 seven days ago.
Since those highs, ADA has fallen 5.89%, but one analyst thinks the cryptocurrency has yet to see “peak hype.”
The analyst Kaleo on Twitter forecast “clear skies” all the way to the previous all-time high.
A move to the high 3s from here is only ~30%. ADA / BTC chart has clear skies all the way to the previous ATH, which is a 48% move higher. I personally don't think it closes that gap fully on *this* move, but just wanted to show there are no clear BTC pair resistances stopping it pic.twitter.com/JKuHqJOSsK
— K A L E O (@CryptoKaleo) August 29, 2021
Why It Matters: The Charles Hoskinson-created Cardano is due to usher in smart contract functionality on Sept. 15, which fueled its rise last week.
See Also: Bitcoin, Ethereum, Dogecoin Take A Breather But Solana Can't Stop Chasing New All-Time Highs
The smart contract buzz has even attracted a paper Dogecoin DOGE/USD millionaire, Glauber Contessoto, to the Cardano fold.
“I’m going to start buying up as much Cardano as humanely possible with every bit of money I start making from now on,” Contessoto told CNBC last week.
Recently, Cardano was also listed on the Japanese cryptocurrency exchange Bitpoint, which sparked a rise in its prices.
Additionally, the project announced the availability of Ethereum smart contracts on Cardano.
Read Next: Cardano Founder Says The Only 'Ethereum Killer' Is Ethereum 2.0
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.